Key contacts
Gabor Lamm
Managing Director, EMBLEM
Andrew Leach
Head of Industry Partnerships and Head of Chemical Biology, EMBL-EBI
Jessica Vamathevan
Head of Strategy
Strengthening translational mechanisms in new research areas
EMBL’s new Programme intends to strengthen key innovation and translation activities and expand successful mechanisms to encompass the proposed new research directions.
One of EMBL’s core missions is to actively engage in technology transfer and industry relations as one more way to aim at societal impact. Innovation and Translation at EMBL will expand to encompass the Programme’s new scientific directions. In addition to building a portfolio of innovation and commercialisation activities, EMBL will broaden and advance research collaborations and technology development via new public–private partnerships. Novel training formats, among other new activities, will further develop an EMBL innovation culture, empower the next generation of EMBL fellows, and diversify current instruments for training and knowledge exchange between EMBL and industry partners. Ultimately, the goal is to empower and equip EMBL scientists and staff to be creative, collaborative, and innovative with a willingness to consider and follow through on entrepreneurial opportunities that arise within their research.

Gabor Lamm
Managing Director, EMBLEM
Andrew Leach
Head of Industry Partnerships and Head of Chemical Biology, EMBL-EBI
Jessica Vamathevan
Head of Strategy
“We aim to ensure that the translational potential of the new scientific directions in this Programme and EMBL’s promising inventions and technologies bring further benefits to scientific endeavour and society.”
EMBL Director General, 2019-2025
Internal and external trainings in the new directions
Expanding and integrating experimental and data services
Coordinating efforts within and between our member states
We harness EMBL’s entrepreneurial spirit through technology transfer programmes and technology spin-offs.
We manage a portfolio of more than 1000 inventions and over 450 patents/copyrights from EMBL-scientists, EMBL–alumni and third parties.
A forum for interaction and knowledge exchange for those employed at the forefront of industrial bioinformatics.
The Programme is designed to form and cultivate long-term, fruitful relationships between EMBL and top-class corporate partners.
A freely-available, large-scale, multi-year, public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation.
We provide open access for researchers to cutting-edge imaging technologies integrating methods in the field of electron and light microscopy.
EMBL’s vision is to advance understanding of ecosystems at the molecular level and study life in context. The result will be fundamental research that expands what we know about life on earth and provides the means to address major global challenges.
This new Programme will expand EMBL’s scope to study the molecular basis of life in the context of changing environments, transforming our understanding of life on earth and informing potential solutions for some of society’s biggest challenges, such as irreversible loss of biodiversity, antimicrobial resistance, pollution, climate change, food security, and emergent pathogens.